Zoetis | ZTS - Operating Profit


Zoetis reported $1.12B in Operating Profit for its fiscal quarter ending in June of 2026.





Operating Profit Change Date
AbbVie USD 6.72B 1.99B Jun/2026
Align Technology USD 191.32M 13.27M Jun/2026
Bayer EUR 3.53B 2.42B Mar/2026
Bristol-Myers Squibb USD 299M 3.07B Jun/2026
Charles River Laboratories USD 119.89M 9K Jun/2026
Coherus Biosciences USD -39.08M 3.65M Dec/2025
Dentsply International USD 32M 506M Mar/2026
Eli Lilly USD 12.46B 2.68B Jun/2026
Henry Schein USD 200M 18M Jun/2026
Idexx Laboratories USD 425.57M 62.98M Jun/2026
Illumina USD 260M 21M Jun/2026
IQVIA Holdings USD 2.6B 2.03B Jun/2026
J&J USD 7.48B 860M Jun/2026
Laboratory Of America USD 456.7M 46.6M Jun/2026
Merck USD 840M 2.72B Jun/2026
Neogen USD 3.1M 6.4M Mar/2026
Pacira USD 9.96M 5.33M Jun/2026
Perrigo USD 23.5M 10.1M Jun/2026
Pfizer USD 667M 4.32B Jun/2026
Phibro Animal Health USD 54.99M 2.36M Dec/2025
Quest Diagnostics USD 459M 60M Jun/2026
Sanofi EUR 2.38B 449M Jun/2026
Sanofi EUR 2.27B 771M Mar/2026
Zoetis USD 1.12B 256M Jun/2026